QQQ   290.05 (-0.11%)
AAPL   114.49 (-2.43%)
MSFT   209.56 (-0.39%)
FB   268.26 (-0.53%)
GOOGL   1,724.68 (-0.67%)
AMZN   3,093.63 (-0.19%)
TSLA   521.06 (+6.42%)
NVDA   524.11 (+0.11%)
BABA   270.35 (-0.14%)
CGC   24.89 (+4.93%)
GE   10.12 (+3.69%)
MU   63.89 (+4.06%)
AMD   85.09 (+0.53%)
T   28.64 (+1.13%)
NIO   53.49 (+8.61%)
F   8.90 (+1.83%)
ACB   7.35 (+3.09%)
GILD   59.56 (-0.91%)
NFLX   480.48 (-1.59%)
BA   211.39 (+5.90%)
DIS   146.03 (+3.52%)
QQQ   290.05 (-0.11%)
AAPL   114.49 (-2.43%)
MSFT   209.56 (-0.39%)
FB   268.26 (-0.53%)
GOOGL   1,724.68 (-0.67%)
AMZN   3,093.63 (-0.19%)
TSLA   521.06 (+6.42%)
NVDA   524.11 (+0.11%)
BABA   270.35 (-0.14%)
CGC   24.89 (+4.93%)
GE   10.12 (+3.69%)
MU   63.89 (+4.06%)
AMD   85.09 (+0.53%)
T   28.64 (+1.13%)
NIO   53.49 (+8.61%)
F   8.90 (+1.83%)
ACB   7.35 (+3.09%)
GILD   59.56 (-0.91%)
NFLX   480.48 (-1.59%)
BA   211.39 (+5.90%)
DIS   146.03 (+3.52%)
QQQ   290.05 (-0.11%)
AAPL   114.49 (-2.43%)
MSFT   209.56 (-0.39%)
FB   268.26 (-0.53%)
GOOGL   1,724.68 (-0.67%)
AMZN   3,093.63 (-0.19%)
TSLA   521.06 (+6.42%)
NVDA   524.11 (+0.11%)
BABA   270.35 (-0.14%)
CGC   24.89 (+4.93%)
GE   10.12 (+3.69%)
MU   63.89 (+4.06%)
AMD   85.09 (+0.53%)
T   28.64 (+1.13%)
NIO   53.49 (+8.61%)
F   8.90 (+1.83%)
ACB   7.35 (+3.09%)
GILD   59.56 (-0.91%)
NFLX   480.48 (-1.59%)
BA   211.39 (+5.90%)
DIS   146.03 (+3.52%)
QQQ   290.05 (-0.11%)
AAPL   114.49 (-2.43%)
MSFT   209.56 (-0.39%)
FB   268.26 (-0.53%)
GOOGL   1,724.68 (-0.67%)
AMZN   3,093.63 (-0.19%)
TSLA   521.06 (+6.42%)
NVDA   524.11 (+0.11%)
BABA   270.35 (-0.14%)
CGC   24.89 (+4.93%)
GE   10.12 (+3.69%)
MU   63.89 (+4.06%)
AMD   85.09 (+0.53%)
T   28.64 (+1.13%)
NIO   53.49 (+8.61%)
F   8.90 (+1.83%)
ACB   7.35 (+3.09%)
GILD   59.56 (-0.91%)
NFLX   480.48 (-1.59%)
BA   211.39 (+5.90%)
DIS   146.03 (+3.52%)
Log in
OTCMKTS:ULGX

Urologix Stock Forecast, Price & News

$0.0030
0.00 (-18.92 %)
(As of 11/20/2020 09:51 PM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.01
Volume957,700 shs
Average Volume37,893 shs
Market Capitalization$63,990.00
P/E RatioN/A
Dividend YieldN/A
Beta1.97
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ULGX
CUSIPN/A
Phone612-475-1400
Employees61

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$63,990.00
Next Earnings DateN/A
OptionableNot Optionable
$0.0030
0.00 (-18.92 %)
(As of 11/20/2020 09:51 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ULGX News and Ratings via Email

Sign-up to receive the latest news and ratings for ULGX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Urologix (OTCMKTS:ULGX) Frequently Asked Questions

How has Urologix's stock been impacted by COVID-19?

Urologix's stock was trading at $0.0032 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ULGX stock has decreased by 6.3% and is now trading at $0.0030.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Urologix?

Wall Street analysts have given Urologix a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Urologix wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Urologix's key competitors?

What other stocks do shareholders of Urologix own?

Who are Urologix's key executives?

Urologix's management team includes the following people:
  • Bryon Merade, Chairman & CEO

What is Urologix's stock symbol?

Urologix trades on the OTCMKTS under the ticker symbol "ULGX."

How do I buy shares of Urologix?

Shares of ULGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Urologix's stock price today?

One share of ULGX stock can currently be purchased for approximately $0.00.

How big of a company is Urologix?

Urologix has a market capitalization of $63,990.00. Urologix employs 61 workers across the globe.

What is Urologix's official website?

The official website for Urologix is www.urologix.com.

How can I contact Urologix?

Urologix's mailing address is 14405 21ST AVE N, MINNEAPOLIS MN, 55447. The company can be reached via phone at 612-475-1400 or via email at [email protected]

This page was last updated on 11/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.